Studies have demonstrated increases in retrieved oocyte numbers [123], elevated anti-Mullerian hormone (AMH) levels, reduced follicle-stimulating hormone (FSH) concentrations, and trends toward improved clinical pregnancy and live birth rates in women with premature ovarian insufficiency [124,125,126]. Here, AMH is linked to Premature ovarian insufficiency.